SPDR S&P Biotech ETF $XBI Stock Sold by Deltec Asset Management LLC

Deltec Asset Management LLC decreased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 35.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,000 shares of the exchange traded fund’s stock after selling 5,000 shares during the quarter. Deltec Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,419,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of XBI. Angeles Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $28,000. Root Financial Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at approximately $31,000. Axiom Investment Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at approximately $26,000. Financial Life Planners purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at approximately $27,000. Finally, Morling Financial Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $36,000.

SPDR S&P Biotech ETF Price Performance

XBI opened at $150.47 on Tuesday. The firm has a fifty day moving average price of $157.13 and a 200 day moving average price of $140.94. SPDR S&P Biotech ETF has a 1 year low of $106.30 and a 1 year high of $169.89. The stock has a market cap of $10.50 billion, a P/E ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.